Advanced HER2+breast cancer

Clinical trials for Advanced HER2+breast cancer explained in plain language.

Never miss a new study

Get alerted when new Advanced HER2+breast cancer trials appear

Sign up with your email to follow new studies for Advanced HER2+breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New pill combo aims to keep advanced breast cancer in check

Disease control Ongoing

This Phase 3 study tests whether adding the targeted drug alpelisib to standard maintenance therapy (trastuzumab and pertuzumab) can help people with advanced HER2-positive breast cancer that has a specific genetic change (PIK3CA mutation) live longer without their cancer growing…

Matched conditions: ADVANCED HER2+BREAST CANCER

Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Sep 20, 2026 00:00 UTC

Advanced HER2+breast cancer

Get alerted when new Advanced HER2+breast cancer trials appear

New pill combo aims to keep advanced breast cancer in check